Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.

doi:10.1007/s10549-007-9627-3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.

Breast cancer research and treatment - 1 May 2008

Johnatty Sharon E, Spurdle Amanda B, Beesley Jonathan, Chen Xiaoqing, Hopper John L, Duffy David L, Chenevix-Trench Georgia

Abstract excerpt

Association studies aimed at identifying breast cancer susceptibility variants in the progesterone receptor (PGR) gene have been previously reported in the literature with conflicting results, ranging from a protective effect conferred by the PROGINS allele in German Caucasian women, to an increased risk for the leucine variant of the Val660Leu (rs1042838) polymorphism in East Anglian cases. We report the results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Heterozygote

Share to Homozygote

Share to Polymorphism, Genetic

Share to Receptors, Progesterone

Share to Risk

Source

Open in PubMed

Identifiers

PMID: 17592773
DOI: 10.1007/s10549-007-9627-3

Genes

Variants

rs518162
rs518162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.